Effect of immunotherapy on autoimmune parameters in children with atopic asthma

There is an increased rate of reported autoantibody production in patients with atopic and nonatopic asthma. The possibility of generating autoantibodies after the induction of immunotherapy can be explained by several mechanisms. One of these is immune deviation from TH2 to TH1 response by t...

Full description

Saved in:
Bibliographic Details
Main Authors: Remziye Tanaç, Esen Demir, Güzide Aksu, Galip Sari, Necil Kütükçüler
Format: Article
Language:English
Published: Hacettepe University Institute of Child Health 2002-10-01
Series:The Turkish Journal of Pediatrics
Online Access:https://turkjpediatr.org/article/view/2991
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849772735336546304
author Remziye Tanaç
Esen Demir
Güzide Aksu
Galip Sari
Necil Kütükçüler
author_facet Remziye Tanaç
Esen Demir
Güzide Aksu
Galip Sari
Necil Kütükçüler
author_sort Remziye Tanaç
collection DOAJ
description There is an increased rate of reported autoantibody production in patients with atopic and nonatopic asthma. The possibility of generating autoantibodies after the induction of immunotherapy can be explained by several mechanisms. One of these is immune deviation from TH2 to TH1 response by the effect of immunotherapy in favor of unregulated response to self-antigens. The other theory is a possible antigenic mimicry enabling autoantibody formation in these patients, Sixty-three atopic asthmatic children were included in the study. The patients were divided into three groups: Group I: patients with atopic bronchial asthma without immunotherapy: Group II: patients receiving immunotherapy for a maximum of 3 years; Group III: patients receiving immunotherapy for 4-5 years. The autoantibodies examined in the study population were anti-nuclear antibody, anti-double stranded DNA, rheumatoid factor, liver-kidney microsomal antibody, anti-mitochondrial antibody, anti-thyroglobulin and anti-microsomal antibody, anti-Smith antibody and lupus anticoagulant. An overall incidence of 17.5% autoantibody positivity was observed in patients, with no statistical significance between the treatment groups. IgG levels were significantly elevated in Group III when compared with Group I. Based on these findings it is suggested, in accordance with other studies, that long-term immunotherapy in the pediatric age group does not cause a significant autoantibody formation other than the overall increased incidence that occurs in asthmatic patients.
format Article
id doaj-art-3498ddb1a62b4f9f82c74be3cd0fcef7
institution DOAJ
issn 0041-4301
2791-6421
language English
publishDate 2002-10-01
publisher Hacettepe University Institute of Child Health
record_format Article
series The Turkish Journal of Pediatrics
spelling doaj-art-3498ddb1a62b4f9f82c74be3cd0fcef72025-08-20T03:02:15ZengHacettepe University Institute of Child HealthThe Turkish Journal of Pediatrics0041-43012791-64212002-10-01444Effect of immunotherapy on autoimmune parameters in children with atopic asthmaRemziye Tanaç0Esen DemirGüzide AksuGalip SariNecil KütükçülerDepartment of Pediatrics, Ege University Faculty of Medicine, Izmir, Turkey. There is an increased rate of reported autoantibody production in patients with atopic and nonatopic asthma. The possibility of generating autoantibodies after the induction of immunotherapy can be explained by several mechanisms. One of these is immune deviation from TH2 to TH1 response by the effect of immunotherapy in favor of unregulated response to self-antigens. The other theory is a possible antigenic mimicry enabling autoantibody formation in these patients, Sixty-three atopic asthmatic children were included in the study. The patients were divided into three groups: Group I: patients with atopic bronchial asthma without immunotherapy: Group II: patients receiving immunotherapy for a maximum of 3 years; Group III: patients receiving immunotherapy for 4-5 years. The autoantibodies examined in the study population were anti-nuclear antibody, anti-double stranded DNA, rheumatoid factor, liver-kidney microsomal antibody, anti-mitochondrial antibody, anti-thyroglobulin and anti-microsomal antibody, anti-Smith antibody and lupus anticoagulant. An overall incidence of 17.5% autoantibody positivity was observed in patients, with no statistical significance between the treatment groups. IgG levels were significantly elevated in Group III when compared with Group I. Based on these findings it is suggested, in accordance with other studies, that long-term immunotherapy in the pediatric age group does not cause a significant autoantibody formation other than the overall increased incidence that occurs in asthmatic patients. https://turkjpediatr.org/article/view/2991
spellingShingle Remziye Tanaç
Esen Demir
Güzide Aksu
Galip Sari
Necil Kütükçüler
Effect of immunotherapy on autoimmune parameters in children with atopic asthma
The Turkish Journal of Pediatrics
title Effect of immunotherapy on autoimmune parameters in children with atopic asthma
title_full Effect of immunotherapy on autoimmune parameters in children with atopic asthma
title_fullStr Effect of immunotherapy on autoimmune parameters in children with atopic asthma
title_full_unstemmed Effect of immunotherapy on autoimmune parameters in children with atopic asthma
title_short Effect of immunotherapy on autoimmune parameters in children with atopic asthma
title_sort effect of immunotherapy on autoimmune parameters in children with atopic asthma
url https://turkjpediatr.org/article/view/2991
work_keys_str_mv AT remziyetanac effectofimmunotherapyonautoimmuneparametersinchildrenwithatopicasthma
AT esendemir effectofimmunotherapyonautoimmuneparametersinchildrenwithatopicasthma
AT guzideaksu effectofimmunotherapyonautoimmuneparametersinchildrenwithatopicasthma
AT galipsari effectofimmunotherapyonautoimmuneparametersinchildrenwithatopicasthma
AT necilkutukculer effectofimmunotherapyonautoimmuneparametersinchildrenwithatopicasthma